Search - tctmd.com

Displaying 1 - 20 of 1706

Sort: Relevancy | Date

Two Neutral IVUS Trials in Complex PCI—and One Positive—Spark Debate

News Conference News ACC 2026

Two Neutral IVUS Trials in Complex PCI—and One Positive—Spark Debate

April 02, 2026

Oral Anticoagulation Alone Best for Stable CAD Patients With AF: Meta-analysis

News Daily News

Oral Anticoagulation Alone Best for Stable CAD Patients With AF: Meta-analysis

Yael L. Maxwell

March 12, 2026

AGENT IDE Midterm Results Still Give DCB an Edge for In-Stent Restenosis

News Conference News CRT 2026

AGENT IDE Midterm Results Still Give DCB an Edge for In-Stent Restenosis

March 11, 2026

Good News for Intravascular Imaging Continues at 5 Years: RENOVATE-COMPLEX-PCI

News Daily News

Good News for Intravascular Imaging Continues at 5 Years: RENOVATE-COMPLEX-PCI

March 10, 2026

CRT 2026: What to Expect in Washington, DC

News Conference News CRT 2026

CRT 2026: What to Expect in Washington, DC

March 04, 2026

News Industry News

Fondazione Ricerca e Innovazione Cardiovascolare and Fundación EPIC Launch PICCOLETO IV-EPIC Clinical Trial

February 13, 2026

IVUS, OCT Each Bring Something to the Table for PCI in Complex Lesions: Meta-analysis

News Daily News

IVUS, OCT Each Bring Something to the Table for PCI in Complex Lesions: Meta-analysis

January 20, 2026

Better LDL Control After STEMI Means Less Neoatherosclerosis

News Daily News

Better LDL Control After STEMI Means Less Neoatherosclerosis

Yael L. Maxwell

December 23, 2025

Prasugrel May Be Better Than Ticagrelor After PCI for Diabetes Patients With MVD

News Conference News AHA 2025

Prasugrel May Be Better Than Ticagrelor After PCI for Diabetes Patients With MVD

November 13, 2025

CELEBRATE: Zalunfiban, a Novel Glycoprotein IIb/IIIa Inhibitor, Helps in STEMI

News Conference News AHA 2025

CELEBRATE: Zalunfiban, a Novel Glycoprotein IIb/IIIa Inhibitor, Helps in STEMI

Michael O'Riordan

November 11, 2025

Anticoagulation Alone Is Best in AF Patients a Year or More Out From PCI

News Conference News AHA 2025

Anticoagulation Alone Is Best in AF Patients a Year or More Out From PCI

November 09, 2025

One Month of Dual Antithrombotic Therapy May Be Enough After PCI in AF Patients

News Conference News AHA 2025

One Month of Dual Antithrombotic Therapy May Be Enough After PCI in AF Patients

November 08, 2025

Ultrathin-Strut DES Performs Well vs Xience in Diabetic Patients: TUXEDO-2

News Conference News TCT 2025

Ultrathin-Strut DES Performs Well vs Xience in Diabetic Patients: TUXEDO-2

November 03, 2025

News Industry News

SMT’s Supraflex Cruz Shows Consistent and Robust Clinical Outcomes Across Key Global Studies Presented at TCT 2025

October 29, 2025

INFINITY-SWEDEHEART: ‘Unlocking’ Stent’s Benefits Seen Over Time

News Conference News TCT 2025

INFINITY-SWEDEHEART: ‘Unlocking’ Device Bests DES Over Time

Michael O'Riordan

October 29, 2025

iFR-Guided Immediate PCI Not Superior to Deferred CMR-Guided Strategy in STEMI

News Conference News TCT 2025

iFR-Guided Immediate PCI Not Superior to Deferred CMR-Guided Strategy in STEMI

Yael L. Maxwell

October 28, 2025

Presentation TCT 2025

TCT 1011: Feasibility Study of Local Antiplatelet Therapy Using an Arterial infusion microcatheter (AIMC) for the Prevention of In-Stent Thrombosis

Presenter: Yi Mao

October 28, 2025

Presentation TCT 2025

TCT 1693: STEMI Due to Left Main Occlusion in a Young Patient: Is Stenting Always Necessary? An Alternative Approach Using Drug-Coated Balloon Therapy

Presenter: Victor Alfonso Jimenez Diaz

October 27, 2025

Presentation TCT 2025

TCT 1006: Dual Antiplatelet Therapy Duration and Risk of Stent Thrombosis in Complex Percutaneous Coronary Intervention: a Meta-Analysis

Presenter: Fiorenzo Simonetti

October 27, 2025

Presentation TCT 2025

TCT 1680: Triple Trouble

Presenter: Mohamed Abo Bakr Elbayoumi

October 27, 2025

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.